{
    "organizations": [],
    "uuid": "7f26f266ddbef510d748ec011381207e7df36594",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-hubei-biocause-says-insurance-unit/brief-hubei-biocause-says-insurance-units-jan-dec-premium-income-totalled-46-1-bln-yuan-idUSH9N1OZ003",
    "ord_in_thread": 0,
    "title": "BRIEF-Hubei Biocause Says Insurance Unit's Jan-Dec Premium Income Totalled 46.1 Bln Yuan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Hubei Biocause Pharmaceutical Co Ltd :\n* SAYS INSURANCE UNIT'S JAN-DEC PREMIUM INCOME TOTALLED 46.1 BILLION YUAN ($7.09 billion) Source text in Chinese: bit.ly/2CQDC8y Further company coverage: ($1 = 6.4977 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-01-08T18:23:00.000+02:00",
    "crawled": "2018-01-09T16:51:24.055+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "hubei",
        "biocause",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "insurance",
        "unit",
        "premium",
        "income",
        "totalled",
        "billion",
        "yuan",
        "billion",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}